Paclitaxel (50 mg) β-(benzoylamino)-α-hydroxy-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2aR,3,4S,4aS,5,6R,9S,10,11S,12S,12aR,12bS-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, benzenepropanoic acid; NSC 125973|Taxol ; Paclitaxel Cayman 10461-50 1540/50 mg 详情
5,6-DiHETE (100 ug) 5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid; 5,6-DiHETE Cayman 10467-100 4219.6/100 ug 详情
5,6-DiHETE (25 ug) 5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid; 5,6-DiHETE Cayman 10467-25 1170.4/25 ug 详情
5,6-DiHETE (250 ug) 5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid; 5,6-DiHETE Cayman 10467-250 规格或产品已更新 详情
5,6-DiHETE (50 ug) 5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid; 5,6-DiHETE Cayman 10467-50 2217.6/50 ug 详情
Erlotinib (1 g) N-(3-ethylnylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; CP 358,774|NSC 718781; Erlotinib Cayman 10483-1 1232/1 g 详情
Erlotinib (250 mg) N-(3-ethylnylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; CP 358,774|NSC 718781; Erlotinib Cayman 10483-250 385/250 mg 详情
Erlotinib (5 g) N-(3-ethylnylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; CP 358,774|NSC 718781; Erlotinib Cayman 10483-5 5390/5 g 详情
Erlotinib (500 mg) N-(3-ethylnylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; CP 358,774|NSC 718781; Erlotinib Cayman 10483-500 693/500 mg 详情
JWH 007-d9 (1 mg) (2-methyl-1-pentyl-1H-indol-3-yl)-1-naphthalenyl-2,2,3,3,4,4,5,5,5-d9-methanone; JWH 007-d9 Cayman 10486-1 1909.6/1 mg 详情
JWH 007-d9 (500 ug) (2-methyl-1-pentyl-1H-indol-3-yl)-1-naphthalenyl-2,2,3,3,4,4,5,5,5-d9-methanone; JWH 007-d9 Cayman 10486-500 1001/500 ug 详情
Capecitabine (1 g) 5’-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine; Ro 09-1978|Xeloda ; Capecitabine Cayman 10487-1 1108.8/1 g 详情
Capecitabine (5 g) 5’-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine; Ro 09-1978|Xeloda ; Capecitabine Cayman 10487-5 4681.6/5 g 详情
Capecitabine (500 mg) 5’-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine; Ro 09-1978|Xeloda ; Capecitabine Cayman 10487-500 585.2/500 mg 详情
Candesartan cilexetil (1 g) 2-ethoxy-1-[[2’-(2H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester-1H-Benzimidazole-7-carboxylic acid; TCV-116; Candesartan cilexetil Cayman 10489-1 1755.6/1 g 详情
Candesartan cilexetil (10 g) 2-ethoxy-1-[[2’-(2H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester-1H-Benzimidazole-7-carboxylic acid; TCV-116; Candesartan cilexetil Cayman 10489-10 12936/10 g 详情
Candesartan cilexetil (5 g) 2-ethoxy-1-[[2’-(2H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester-1H-Benzimidazole-7-carboxylic acid; TCV-116; Candesartan cilexetil Cayman 10489-5 7392/5 g 详情
Candesartan cilexetil (500 mg) 2-ethoxy-1-[[2’-(2H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester-1H-Benzimidazole-7-carboxylic acid; TCV-116; Candesartan cilexetil Cayman 10489-500 924/500 mg 详情
(S)-AM1241 (1 mg) (2-iodo-5-nitrophenyl)[1-[[(2S)-1-methyl-2-piperidinyl]methyl]-1H-indol-3-yl]-methanone; (-)-AM1241; (S)-AM1241 Cayman 10490-1 770/1 mg 详情
(S)-AM1241 (10 mg) (2-iodo-5-nitrophenyl)[1-[[(2S)-1-methyl-2-piperidinyl]methyl]-1H-indol-3-yl]-methanone; (-)-AM1241; (S)-AM1241 Cayman 10490-10 6160/10 mg 详情
(S)-AM1241 (25 mg) (2-iodo-5-nitrophenyl)[1-[[(2S)-1-methyl-2-piperidinyl]methyl]-1H-indol-3-yl]-methanone; (-)-AM1241; (S)-AM1241 Cayman 10490-25 13475/25 mg 详情
(S)-AM1241 (5 mg) (2-iodo-5-nitrophenyl)[1-[[(2S)-1-methyl-2-piperidinyl]methyl]-1H-indol-3-yl]-methanone; (-)-AM1241; (S)-AM1241 Cayman 10490-5 3465/5 mg 详情
(R)-AM1241 (1 mg) (2-iodo-5-nitrophenyl)[1-[[(2R)-1-methyl-2-piperidinyl]methyl]-1H-indol-3-yl]methanone; (+)-AM1241; (R)-AM1241 Cayman 10491-1 770/1 mg 详情
(R)-AM1241 (10 mg) (2-iodo-5-nitrophenyl)[1-[[(2R)-1-methyl-2-piperidinyl]methyl]-1H-indol-3-yl]methanone; (+)-AM1241; (R)-AM1241 Cayman 10491-10 6160/10 mg 详情
(R)-AM1241 (25 mg) (2-iodo-5-nitrophenyl)[1-[[(2R)-1-methyl-2-piperidinyl]methyl]-1H-indol-3-yl]methanone; (+)-AM1241; (R)-AM1241 Cayman 10491-25 13475/25 mg 详情
(R)-AM1241 (5 mg) (2-iodo-5-nitrophenyl)[1-[[(2R)-1-methyl-2-piperidinyl]methyl]-1H-indol-3-yl]methanone; (+)-AM1241; (R)-AM1241 Cayman 10491-5 3465/5 mg 详情
Atorvastatin (10 mg) 2-(4-fluorophenyl)-βR,δR-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid; Cardyl|Lipitor ; Atorvastatin Cayman 10493-10 539/10 mg 详情
Atorvastatin (25 mg) 2-(4-fluorophenyl)-βR,δR-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid; Cardyl|Lipitor ; Atorvastatin Cayman 10493-25 770/25 mg 详情
Atorvastatin (5 mg) 2-(4-fluorophenyl)-βR,δR-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid; Cardyl|Lipitor ; Atorvastatin Cayman 10493-5 385/5 mg 详情
Atorvastatin (50 mg) 2-(4-fluorophenyl)-βR,δR-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid; Cardyl|Lipitor ; Atorvastatin Cayman 10493-50 1355.2/50 mg 详情
4-iodo-SAHA (100 mg) N1-hydroxy-N8-(4-iodophenyl) octanediamide; 4-iodo-SAHA Cayman 10495-100 2109.8/100 mg 详情
4-iodo-SAHA (250 mg) N1-hydroxy-N8-(4-iodophenyl) octanediamide; 4-iodo-SAHA Cayman 10495-250 4989.6/250 mg 详情
4-iodo-SAHA (50 mg) N1-hydroxy-N8-(4-iodophenyl) octanediamide; 4-iodo-SAHA Cayman 10495-50 1108.8/50 mg 详情
4-iodo-SAHA (500 mg) N1-hydroxy-N8-(4-iodophenyl) octanediamide; 4-iodo-SAHA Cayman 10495-500 8870.4/500 mg 详情
Sulforaphane (10 mg) 1-isothiocyanato-4-(methylsulfinyl)-butane; Sulforaphane Cayman 10496-10 970.2/10 mg 详情
Sulforaphane (25 mg) 1-isothiocyanato-4-(methylsulfinyl)-butane; Sulforaphane Cayman 10496-25 2294.6/25 mg 详情
Sulforaphane (5 mg) 1-isothiocyanato-4-(methylsulfinyl)-butane; Sulforaphane Cayman 10496-5 508.2/5 mg 详情
CAY10632 (1 mg) 14Z,17Z,20Z,23Z,26Z,29Z-dotriacontahexaenoic acid; CAY10632 Cayman 10497-1 规格或产品已更新 详情
CAY10632 (100 ug) 14Z,17Z,20Z,23Z,26Z,29Z-dotriacontahexaenoic acid; CAY10632 Cayman 10497-100 5436.2/100 ug 详情
CAY10632 (5 mg) 14Z,17Z,20Z,23Z,26Z,29Z-dotriacontahexaenoic acid; CAY10632 Cayman 10497-5 规格或产品已更新 详情
CAY10632 (500 ug) 14Z,17Z,20Z,23Z,26Z,29Z-dotriacontahexaenoic acid; CAY10632 Cayman 10497-500 规格或产品已更新 详情
Prostaglandin Screening Library I (96-Well) (100 ul) Prostaglandin Compound Screening Library 1; Prostaglandin Screening Library I (96-Well) Cayman 10501-100 23454.2/100 ul 详情
Prostaglandin Screening Library I (96-Well) (200 ul) Prostaglandin Compound Screening Library 1; Prostaglandin Screening Library I (96-Well) Cayman 10501-200 42211.4/200 ul 详情
Prostaglandin Screening Library I (96-Well) (50 ul) Prostaglandin Compound Screening Library 1; Prostaglandin Screening Library I (96-Well) Cayman 10501-50 14861/50 ul 详情
Prostaglandin Screening Library II (96-Well) (100 ul) Prostaglandin Compound Screening Library 2; Prostaglandin Screening Library II (96-Well) Cayman 10502-100 23454.2/100 ul 详情
Prostaglandin Screening Library II (96-Well) (200 ul) Prostaglandin Compound Screening Library 2; Prostaglandin Screening Library II (96-Well) Cayman 10502-200 42211.4/200 ul 详情
Prostaglandin Screening Library II (96-Well) (50 ul) Prostaglandin Compound Screening Library 2; Prostaglandin Screening Library II (96-Well) Cayman 10502-50 14861/50 ul 详情
Prostaglandin Screening Library III (96-Well) (100 ul) Prostaglandin Compound Screening Library 3; Prostaglandin Screening Library III (96-Well) Cayman 10503-100 23454.2/100 ul 详情
Prostaglandin Screening Library III (96-Well) (200 ul) Prostaglandin Compound Screening Library 3; Prostaglandin Screening Library III (96-Well) Cayman 10503-200 42211.4/200 ul 详情
Prostaglandin Screening Library III (96-Well) (50 ul) Prostaglandin Compound Screening Library 3; Prostaglandin Screening Library III (96-Well) Cayman 10503-50 14861/50 ul 详情
首页 公司简介 新闻中心 产品中心 特色产品 技术专栏 在线订购 联系我们

版权所有 艾美捷科技有限公司

地址:武汉市洪山区光谷大道35号光谷总部国际二期时代1栋13楼 邮政编码:430074

电话:+86-027-59626688 全国免费技术支持: 400-6800-868 传真:+86-027-59716800

鄂ICP备10204150号

Abbkine Scientific   亚科因科技